feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / New Study Reveals Cold's Nasal Battleground

New Study Reveals Cold's Nasal Battleground

21 Jan

•

Summary

  • Nasal cell response to rhinovirus determines cold symptom severity.
  • Interferons block viruses; delayed response leads to infection.
  • Temperature and pollution can affect nasal immune response.
New Study Reveals Cold's Nasal Battleground

New research offers a detailed look into why some people experience severe cold symptoms while others remain unaffected. The study, published on January 19, 2026, in Cell Press Blue, highlights the critical role of nasal cells' response to rhinovirus, the primary cause of the common cold.

Scientists observed that a swift immune reaction, characterized by the release of interferons, effectively prevents the virus from infecting more than 1% of nasal cells. These proteins act as a defense, blocking viral entry and spread, thus averting illness.

Conversely, when interferons are delayed or compromised, the virus proliferates. This impaired response can lead to 30% or more of cells becoming infected, triggering inflammation and excess mucus production—the hallmarks of a common cold.

trending

Nurses infected with Nipah virus

trending

Army vehicle plunges in Doda

trending

Warriorz edge Giants in WPL

trending

Delhi weather: Yellow alert issued

trending

Volkswagen shares top DAX

trending

Punjab rain yellow alert

trending

NEET MDS 2026 exam date

trending

Casemiro leaving Manchester United

trending

Rajeshwari Gayakwad stars in WPL

Several factors can influence this immune response. Recent viral infections may prime the nasal passages for a quicker defense. Cooler air temperatures, common in winter, could slow interferon production, giving viruses an advantage. Furthermore, exposure to environmental irritants like pollution or cigarette smoke can detrimentally alter the immune reaction, increasing susceptibility to severe symptoms.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The Yale study found that the severity of cold symptoms depends on how quickly nasal cells respond to the rhinovirus infection by releasing interferons.
Interferons are proteins that block viruses from entering cells and spreading, preventing infection if released quickly enough by the immune system.
Yes, inhaling pollution or cigarette smoke can negatively impact the nasal immune response, potentially leading to more severe cold symptoms.

Read more news on

Healthside-arrow

You may also like

Adenovirus Spreading: Know the Flu-Like Symptoms

23 Dec, 2025 • 167 reads

article image

Holiday Germs Spike: Flu, Norovirus, COVID-19 Surging

22 Dec, 2025 • 184 reads

article image

New 'Untreatable' Virus Spreads Globally

21 Dec, 2025 • 181 reads

article image

Flu Season Low, But New Virus Strain Emerges

13 Dec, 2025 • 221 reads

article image

Cold, Flu, or COVID? Spot the Difference Fast

9 Dec, 2025 • 210 reads

article image